Refine
Has Fulltext
- yes (9)
Is part of the Bibliography
- yes (9)
Document Type
- Journal article (8)
- Doctoral Thesis (1)
Language
- English (9)
Keywords
- MYC (4)
- MIZ1 (2)
- ATM (1)
- B-MYB (1)
- COX2 expression (1)
- CRC (1)
- CRISPR-Cas9 (1)
- CX5461 (1)
- ChIP-sequencing (1)
- DNA double-strand breaks (1)
- DNA-PK (1)
- IR (1)
- JUN (1)
- Myb-MuvB (1)
- NONO (1)
- NRF2 (1)
- NSCLC (1)
- PI3K (1)
- PTEN (1)
- RNA (1)
- RNAPOL1 (1)
- Transcription (1)
- WDR5 (1)
- YAP (1)
- aberrant transcripts (1)
- cancer (1)
- cancer biology (1)
- cell biology (1)
- enhancer (1)
- genome integrity (1)
- human (1)
- lung cancer (1)
- mathematical modeling (1)
- melanoma malignancy (1)
- mitotic genes (1)
- motor axons (1)
- mouse (1)
- mouse model (1)
- non-small cell lung cancer (1)
- promoter affinity (1)
- radiotherapy (1)
- repair and replication (1)
- ribosome (1)
- transcription (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (6)
- Pathologisches Institut (4)
- Comprehensive Cancer Center Mainfranken (2)
- Klinik und Poliklinik für Strahlentherapie (2)
- Rudolf-Virchow-Zentrum (2)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Graduate School of Life Sciences (1)
- Institut für Klinische Biochemie und Pathobiochemie (1)
- Institut für Klinische Neurobiologie (1)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (1)
Enhanced expression of the MYC transcription factor is observed in the majority of tumors. Two seemingly conflicting models have been proposed for its function: one proposes that MYC enhances expression of all genes, while the other model suggests gene-specific regulation. Here, we have explored the hypothesis that specific gene expression profiles arise since promoters differ in affinity for MYC and high-affinity promoters are fully occupied by physiological levels of MYC. We determined cellular MYC levels and used RNA- and ChIP-sequencing to correlate promoter occupancy with gene expression at different concentrations of MYC. Mathematical modeling showed that binding affinities for interactions of MYC with DNA and with core promoter-bound factors, such as WDR5, are sufficient to explain promoter occupancies observed in vivo. Importantly, promoter affinity stratifies different biological processes that are regulated by MYC, explaining why tumor-specific MYC levels induce specific gene expression programs and alter defined biological properties of cells.